PolyPid Ltd.
NASDAQ:PYPDBiotechnology
+$0.39 today
- Market cap
- $133.25M
- Beta
- 1.43
- P/E (TTM)
- -2.7
- EPS (TTM)
- -$1.53
Volume 0.30M
Average 0.09M
PYPD EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
PolyPid Ltd.NASDAQ: PYPD
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$7.73M, compared with -$7.58M a year earlier. Trailing-twelve-month EBITDA was -$32.68M.
Context
- EBITDA grew in size in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 2 analysts of $0 (+100.0%) for the fiscal year ending Dec 2026, a step up from the -23.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$7.73M+4.9% QoQ
- Last fiscal yearDec 2025
- -$31.86M-23.3% YoY
- LTMMar 2026
- -$32.68M-11.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -2.0% | +100.0% | +102.0 pp |
| 1 year | -23.3% | +100.0% | +123.3 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (31.86M) USD
- Year-over-year change
- -23.3%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (31.86M) | -23.3% |
| FY2024 | 2024-12-31 | (25.83M) | -27.5% |
| FY2023 | 2023-12-31 | (20.26M) | +44.3% |
| FY2022 | 2022-12-31 | (36.37M) | +12.3% |
| FY2021 | 2021-12-31 | (41.48M) | — |
EBITDA vs competitors
How PYPD compares with its peers on the latest reported figures
- PYPD's LTM Mar 2026 EBITDA of -$32.68M is the 5th highest of the 7 companies compared; the peer median is -$27.97M.
- Its year-over-year change of -11.5% is the 4th highest of 7, against a peer median of -17.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $12.18M | +130.3% | — | 34.7% | |
| LTM Mar 2026 | -$14.89M | -54.8% | — | — | |
| LTM Mar 2026 | -$27.92M | +15.6% | — | — | |
| LTM Mar 2026 | -$28.02M | +27.0% | — | — | |
| LTM Mar 2026 | -$32.68M | -11.5% | — | — | |
| LTM Mar 2026 | -$40.92M | -50.5% | — | — | |
| LTM Dec 2025 | -$77.62M | -86.2% | — | 292.4% | |
| Peer median (excluding PYPD) | -$27.97M | -17.5% | — | 163.5% | |
Competitors are the stored peer set for PYPD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.12M | 1.72M | 0 | 0 | 0 |
| Gross Profit | (1.12M) | (1.72M) | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 30.42M | 27.99M | 16.15M | 22.81M | 23.81M |
| Selling, General & Admin | 12.45M | 10.9M | 6.72M | 5.22M | 9.16M |
| Operating Expenses | 42.03M | 37.17M | 22.87M | 28.03M | 32.97M |
| Depreciation & Amortization | 1.12M | 1.72M | 1.82M | 1.62M | 1.62M |
| EBITDA | (41.48M) | (36.37M) | (20.26M) | (25.83M) | (31.86M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (43.15M) | (38.89M) | (22.87M) | (28.03M) | (32.97M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 468K | 267K | 548K | 442K | 0 |
| Interest Expense | 0 | 1.34M | 1.71M | 1.53M | 685K |
| Other Income / Expenses | 544K | (540K) | (929K) | (951K) | (1.2M) |
| Income Before Tax | (42.6M) | (39.43M) | (23.8M) | (28.98M) | (34.16M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 129K | 69K | 42K | 5K |
| Net Income | (40.71M) | (39.53M) | (23.87M) | (29.02M) | (34.17M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (67.80) | (61.20) | (16.99) | (4.91) | (2.09) |
| EPS (Diluted) | (67.80) | (61.20) | (16.99) | (4.91) | (2.09) |
| Weighted Avg Shares | 1.25M | 1.3M | 1.4M | 5.91M | 16.35M |
| Weighted Avg Shares (Diluted) | 1.25M | 1.3M | 1.4M | 5.91M | 16.35M |
PolyPid Ltd.
NASDAQ:PYPD
Intrinsic Alpha fair value
Locked
Current Price
$6.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.